Web Accessible Pharmaceutical Database
Department
Electrical and Computer Engineering
Major
Computer Engineering
Research Advisor
Stanley, R. Joe
Advisor's Department
Electrical and Computer Engineering
Funding Source
Missouri S&T Opportunities for Undergraduate Research Experiences (OURE) Program; DERMVIS Research Group
Abstract
Currently, drug reactions account for at least seven percent of all hospital admissions worldwide (1). Additionally, potential adverse drug reactions occur in at least 3.7% of all hospitalized patients (2). Post-marketing drug surveillance data is the main source of safety data worldwide. It was post-marketing data that led to withdrawal of a number of drugs that were associated with severe and fatal drug reactions. This information can be found in the Adverse Events Reporting System (AERS) and MedWatch, which are difficult to access and quickly understand by physicians. Creating a website accessible from a computer or mobile device will display the data on adverse drug interaction trends using visual information, such as graphs, and would assist with drug surveillance. Using methods like rolling averages will help identify the adverse effect for a particular drug. Since this database is maintained voluntarily the quality of information is poor. This is the main obstacle in obtaining results.
Biography
David is a junior at Missouri S&T majoring in Computer Engineering with a minor in Physics. This is Madsen’s first year in the OURE and DERMVIS and has assisted in PhD research. Madsen has had clinic and intern/co-op experience with small and large companies. He has participated with Missouri S&T Robotics Competition Team. Madsen will graduate in May, 2012 and will peruse a Masters.
Research Category
Engineering
Presentation Type
Oral Presentation
Document Type
Presentation
Location
Ozark Room
Presentation Date
06 Apr 2011, 11:00 am - 11:30 am
Web Accessible Pharmaceutical Database
Ozark Room
Currently, drug reactions account for at least seven percent of all hospital admissions worldwide (1). Additionally, potential adverse drug reactions occur in at least 3.7% of all hospitalized patients (2). Post-marketing drug surveillance data is the main source of safety data worldwide. It was post-marketing data that led to withdrawal of a number of drugs that were associated with severe and fatal drug reactions. This information can be found in the Adverse Events Reporting System (AERS) and MedWatch, which are difficult to access and quickly understand by physicians. Creating a website accessible from a computer or mobile device will display the data on adverse drug interaction trends using visual information, such as graphs, and would assist with drug surveillance. Using methods like rolling averages will help identify the adverse effect for a particular drug. Since this database is maintained voluntarily the quality of information is poor. This is the main obstacle in obtaining results.
